Ovarian/JJ
and/CC
breast/NN
cytotoxic/JJ
T/NN
lymphocytes/NNS
can/MD
recognize/VB
peptides/NNS
from/IN
the/DT
amino/NN
enhancer/NN
of/IN
split/JJ
protein/NN
of/IN
the/DT
Notch/NN
complex/NN
./.

In/IN
this/DT
study/NN
we/PRP
investigated/VBD
recognition/NN
by/IN
ovarian/JJ
tumor/NN
associated/JJ
lymphocyte/NN
(/(
OVTAL/NN
)/)
,/,
and/CC
breast/NN
tumor/NN
associated/JJ
lymphocytes/NNS
(/(
BRTAL/NNS
)/)
,/,
of/IN
peptides/NNS
corresponding/VBG
to/TO
the/DT
sequence/NN
125-135/CD
of/IN
the/DT
Aminoenhancer/NN
of/IN
split/JJ
(/(
AES/NN
)/)
protein/NN
./.
=====
Three/CD
of/IN
these/DT
peptides/NNS
designated/VBN
as/IN
G75:AES1/2/NN
(/(
128-135/CD
)/)
,/,
G60: AES1/2/NN
(/(
127-137/CD
)/)
and/CC
G61: AES1/2/NN
(/(
125-133/CD
)/)
correspond/VBP
to/TO
the/DT
wildtype/JJ
AES/NN
sequence/NN
,/,
while/IN
the/DT
fourth/JJ
G76:GPLTPLPV/NN
,/,
AES1/2/NN
(/(
128-135/CD
)/)
corresponds/VBZ
to/TO
a/DT
variant/JJ
sequence/NN
of/IN
the/DT
peptide/NN
G75/NN
with/IN
the/DT
N-terminal/JJ
Leu/NN
substituted/VBN
to/TO
glycine/NN
./.
=====
These/DT
sequences/NNS
were/VBD
chosen/VBN
for/IN
study/NN
because/IN
mass-spectrometric/JJ
analysis/NN
(/(
MS/NN
)/)
of/IN
a/DT
CTL/NN
active/JJ
HPLC/NN
peptide/NN
fraction/NN
eluted/VBN
from/IN
immunoaffinity/NN
precipitated/JJ
HLA-A2/NN
molecule/NN
,/,
revealed/VBD
:/:
(/(
a/LS
)/)
the/DT
presence/NN
of/IN
an/DT
ion/NN
with/IN
a/DT
mass-to-charge/JJ
ratio/NN
(/(
m/z/NN
)/)
of/IN
793/CD
which/WDT
was/VBD
more/RBR
abundant/JJ
than/IN
other/JJ
ions/NNS
of/IN
similar/JJ
masses/NNS
;/:
(/(
b/LS
)/)
the/DT
tentatively/RB
reconstituted/VBN
sequence/NN
of/IN
the/DT
ion/NN
793/CD
matched/VBD
the/DT
sequence/NN
of/IN
peptide/NN
G76/NN
./.
=====
We/PRP
found/VBD
that/IN
AES/NN
peptides/NNS
G75/NN
(/(
128-135/CD
)/)
and/CC
G76/NN
(/(
128-135/CD
)/)
(/(
L128G/NN
)/)
reconstituted/VBD
CTL/NN
recognition/NN
at/IN
concentrations/NNS
ranging/VBG
between/IN
200-500/CD
nM/NN
./.
=====
These/DT
concentrations/NNS
are/VBP
lower/JJR
than/IN
concentrations/NNS
reported/VBN
to/TO
activate/VB
effector/NN
function/NN
of/IN
CTL/NN
recognizing/VBG
other/JJ
epithelial/JJ
tumor/NN
Ag/NN
./.
=====
Furthermore/RB
,/,
analysis/NN
with/IN
cloned/VBN
CD8+/JJ
T/NN
cells/NNS
indicated/VBD
that/IN
G75/NN
and/CC
G76/NN
were/VBD
not/RB
cross-reactive/JJ
specificities/NNS
,/,
suggesting/VBG
a/DT
key/JJ
role/NN
for/IN
the/DT
N-terminal/JJ
residues/NNS
of/IN
the/DT
variant/JJ
peptide/NN
in/IN
dictating/VBG
specificities/NNS
./.
=====
Since/IN
the/DT
AES/NN
proteins/NNS
are/VBP
part/NN
of/IN
a/DT
set/NN
of/IN
transcriptional/JJ
repressors/NNS
encoded/VBN
by/IN
the/DT
Enhancer/NN
of/IN
split/JJ
[/(
E(spl)/NN
]/)
genes/NNS
,/,
and/CC
since/IN
these/DT
repressors/NNS
are/VBP
activated/VBN
to/TO
suppress/VB
cell/NN
differentiation/NN
in/IN
response/NN
to/TO
Notch/NN
receptors/NNS
signalling/NN
,/,
the/DT
AES/NN
peptides/NNS
may/MD
represent/VB
a/DT
novel/JJ
class/NN
of/IN
self-antigens/NNS
that/WDT
deserve/VBP
further/JJ
consideration/NN
as/IN
tumor/NN
Ag/NN
in/IN
epithelial/JJ
cancers/NNS
./.